Analystreport

Quest Diagnostics (NYSE:DGX) had its price target raised by analysts at Barclays PLC from $210.00 to $225.00. They now have an "overweight" rating on the stock.

Quest Diagnostics Incorporated  (DGX) 
Last quest diagnostics incorporated earnings: 4/22 06:45 am Check Earnings Report
US:NYSE Investor Relations: ir.questdiagnostics.com